Gaarenstroom KN - Search Results

1

Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB. Gaarenstroom KN, et al. Gynecol Oncol. 2000 Apr;77(1):164-70. doi: 10.1006/gyno.2000.5732. Gynecol Oncol. 2000. PMID: 10739706

2

Interdepartmental Spread of Innovations: A Multicentre Study of the Enhanced Recovery After Surgery Programme.

de Groot JJA, Maessen JMC, Dejong CHC, Winkens B, Kruitwagen RFPM, Slangen BFM, van der Weijden T; all the members of the study group. de Groot JJA, et al. World J Surg. 2018 Aug;42(8):2348-2355. doi: 10.1007/s00268-018-4495-z. World J Surg. 2018. PMID: 29387957 Free PMC article.

3

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.

Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Bonfrer JM, et al. Among authors: gaarenstroom kn. Gynecol Oncol. 1994 Dec;55(3 Pt 1):371-5. doi: 10.1006/gyno.1994.1309. Gynecol Oncol. 1994. PMID: 7530676

4

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Gallee MP, Hart AA, Müller M, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Cancer. 1994 Oct 15;74(8):2307-13. doi: 10.1002/1097-0142(19941015)74:8<2307::aid-cncr2820740815>3.0.co;2-x. Cancer. 1994. PMID: 7922982

5

HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.

van Bommel PF, van den Brule AJ, Helmerhorst TJ, Gallee MP, Gaarenstroom KN, Walboomers JM, Meijer CJ, Kenemans P. van Bommel PF, et al. Among authors: gaarenstroom kn. Gynecol Oncol. 1993 Mar;48(3):333-7. doi: 10.1006/gyno.1993.1058. Gynecol Oncol. 1993. PMID: 8385059

6

Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.

Gaarenstroom KN, Bonfrer JM, Kenter GG, Korse CM, Hart AA, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Cancer. 1995 Sep 1;76(5):807-13. doi: 10.1002/1097-0142(19950901)76:5<807::aid-cncr2820760515>3.0.co;2-m. Cancer. 1995. PMID: 8625184

7

Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.

Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Bonfrer JM, et al. Among authors: gaarenstroom kn. Anticancer Res. 1997 May-Jun;17(3C):2329-34. Anticancer Res. 1997. PMID: 9245246

8

Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.

Gaarenstroom KN, Bonfrer JM, Korse CM, Kenter GG, Kenemans P. Gaarenstroom KN, et al. Anticancer Res. 1997 Jul-Aug;17(4B):2955-8. Anticancer Res. 1997. PMID: 9329574

9

Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions.

Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, Vergote I. Gaarenstroom KN, et al. Int J Gynecol Cancer. 2003 Jul-Aug;13(4):522-7. doi: 10.1046/j.1525-1438.2003.13304.x. Int J Gynecol Cancer. 2003. PMID: 12911732

10

Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer.

Trimbos JB, Lambeek AF, Peters AA, Wolterbeek R, Gaarenstroom KN, Fleuren GJ, Kenter GG. Trimbos JB, et al. Among authors: gaarenstroom kn. Gynecol Oncol. 2004 Oct;95(1):77-81. doi: 10.1016/j.ygyno.2004.06.025. Gynecol Oncol. 2004. PMID: 15385113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters